Los puntos clave no están disponibles para este artículo en este momento.
Ibrutinib was associated with significantly increased risks of both hypertension and atrial fibrillation.
Caldeira et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: